TECENTRIQ

Indicated For

Metastatic non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), adjuvant NSCLC

About This Medication

# Genentech Oncology Co-pay Assistance Program Patient Guide: How to Get TECENTRIQ (atezolizumab) at Low or No Cost TECENTRIQ (atezolizumab) is an immunotherapy drug used to treat certain types of cancer, such as lung cancer, bladder cancer, and breast cancer, by helping your immune system fight cancer cells. The **Genentech Oncology Co-pay Assistance Program** helps eligible patients reduce out-of-pocket costs for TECENTRIQ, potentially paying as little as $0 per treatment if you have commercial insurance, with additional support through the Genentech Patient Foundation for those with public insurance or no insurance. ## About TECENTRIQ and Why Assistance Matters **TECENTRIQ (atezolizumab)** is a prescription medication administered via IV infusion in a doctor's office, hospital, or pharmacy. It's FDA-approved for specific cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma (HCC), melanoma, and others when used alone or with other treatments. Cancer treatment can be expensive, with costs for infusions, co-pays, co-insurance, or deductibles adding up quickly. This program from **Genentech** aims to make TECENTRIQ more accessible so you can focus on your health. ## Who Qualifies for the Program? Eligibility focuses on your insurance type, prescription details, and other criteria. Key groups include: - **Commercially insured patients**: Employer plans or marketplace insurance qualify for co-pay help. - **Public or no insurance**: Genentech Patient Foundation may provide free medicine if you meet financial need. **Basic requirements**: - Prescribed TECENTRIQ for an FDA-approved use. - 18 years or older, or with a caregiver/legal authorization. - Not enrolled in federal/state government programs like Medicare or Medicaid for reimbursement (co-pay program exclusion; Patient Foundation has separate rules). **Income Eligibility Breakdown** Specific income thresholds are not publicly detailed in program materials, as eligibility emphasizes insurance status and financial need confirmed during application. The Genentech Patient Foundation assesses household income relative to Federal Poverty Level (FPL), but exact percentages aren't specified. | Household Size | Estimated Income Threshold | Notes | |---------------|----------------------------|-------| | Individual | Not specified | Based on financial need and insurance; use eligibility tool online. | | Couple | Not specified | Patient Foundation may cover up to certain FPL limits. | | Family of 3 | Not specified | Call for personalized assessment. | | Family of 4+ | Not specified | Excludes government-reimbursed patients. | *Note: Confirm your status by calling (888) 249-4918 or using online tools, as criteria can change.* ## Insurance Requirements - **Commercial insurance**: Primary option; program covers co-pays, co-insurance, deductibles (eligible patients may pay $0). - **Public insurance (Medicare/Medicaid)**: Not eligible for co-pay program; refer to Genentech Patient Foundation or independent foundations. - **No insurance**: Patient Foundation provides free TECENTRIQ if financially eligible. **Important**: Program not valid if prescription is reimbursed by government programs. Check Terms & Conditions on CopayAssistanceNow.com.[2][5] ## Step-by-Step Application Process 1. **Verify eligibility**: Visit CopayAssistanceNow.com or call (855) MY-COPAY (855-692-6729), 9am-8pm ET, M-F (or (888) 249-4918 for TECENTRIQ-specific questions).[1][2] 2. **Gather documents**: Patient Consent Form and Prescriber Service Form (doctor completes Prescriber Foundation Form for Patient Foundation).[3] 3. **Apply online**: Go to https://www.genentech-access.com/patient/brands/tecentriq/how-we-help-you.html or CopayAssistanceNow.com. For Patient Foundation, use GenentechPatientFoundation.com or download forms.[3] 4. **Submit**: Online, fax (833-999-4363), or text photo (650-877-1111). Both forms required.[3] 5. **Wait for approval**: Processed in about 5 business days; office contacted with outcome.[3] 6. **Receive help**: Co-pay card or free medicine shipped to pharmacy, physician office, or hospital. **Reauthorization**: Required; renew as needed based on treatment cycle. ## Timeline and Delivery - **Processing**: 5 business days after receiving both forms.[3] - **Delivery**: Direct to pharmacy, doctor's office, or hospital—no home delivery specified. - **Ongoing**: Benefits have limits; reapply/reauthorize for refills. ## Alternatives if Denied - **Independent co-pay foundations**: Genentech refers eligible patients (call (888) 249-4918).[8] - **Genentech Patient Foundation**: If not initially considered, reapply if uninsured/underinsured.[7][10] - **Genentech Access Solutions**: Free navigation for coverage options (same phone). - **State programs**: Check local resources for cancer care assistance. - **Manufacturer alternatives**: No biosimilars for TECENTRIQ currently. If denied, ask for reasons and appeal or explore Patient Foundation. ## Disclaimer This guide is for informational purposes only and based on publicly available data as of latest updates. Eligibility, benefits, and terms can change; always verify with Genentech at (888) 249-4918 or official sites. Not medical/financial advice—consult your doctor and advisor. Program excludes government-reimbursed prescriptions; full Terms & Conditions apply. Genentech not liable for application errors.

Program information last verified: March 30, 2026